Literature DB >> 20531231

Associations of depression with the transition to menopause.

Ellen W Freeman1.   

Abstract

OBJECTIVES: The aims of this study were to identify the risk of depression in the transition to menopause in women with and without a history of depression and to consider that the changing hormonal milieu is one of multiple risk factors for perimenopausal depression.
METHOD: A review of epidemiologic studies of depressed mood in the menopausal transition since the State-of-Science Report of the National Institutes of Health in 2005 was conducted.
RESULTS: Recent longitudinal cohort studies indicate that the likelihood of depressed mood in the menopausal transition is approximately 30% to three times greater compared with that during premenopause. Women with a history of depression are nearly five times more likely to have a diagnosis of major depression in the menopausal transition, whereas women with no history of depression are two to four times more likely to report depressed mood compared with premenopausal women. In some studies, the changing hormonal milieu is significantly associated with depressive symptoms in the menopausal transition. Other risk factors for depressed mood in perimenopausal women include poor sleep, hot flashes, stressful or negative life events, employment status, age, and race.
CONCLUSIONS: The findings support the concept that the menopausal transition is a "window of vulnerability" for some women and is framed by the changing hormonal milieu of ovarian aging.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20531231     DOI: 10.1097/gme.0b013e3181db9f8b

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  57 in total

Review 1.  Bipolar Disorder in the Menopausal Transition.

Authors:  Dawn Truong; Wendy Marsh
Journal:  Curr Psychiatry Rep       Date:  2019-11-25       Impact factor: 5.285

Review 2.  Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.

Authors:  Valérie A Damoiseaux; Johannes H Proost; Vincent C R Jiawan; Barbro N Melgert
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

Review 3.  Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease.

Authors:  Joyce T Bromberger; Cynthia Neill Epperson
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

Review 4.  Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model.

Authors:  Jennifer L Gordon; Susan S Girdler; Samantha E Meltzer-Brody; Catherine S Stika; Rebecca C Thurston; Crystal T Clark; Beth A Prairie; Eydie Moses-Kolko; Hadine Joffe; Katherine L Wisner
Journal:  Am J Psychiatry       Date:  2015-01-13       Impact factor: 18.112

5.  Associations between ovarian hormones and emotional eating across the menstrual cycle: Do ovulatory shifts in hormones matter?

Authors:  Natasha Fowler; Pamela K Keel; S Alexandra Burt; Michael Neale; Steven Boker; Cheryl L Sisk; Kelly L Klump
Journal:  Int J Eat Disord       Date:  2019-01-15       Impact factor: 4.861

6.  Ovariectomy results in inbred strain-specific increases in anxiety-like behavior in mice.

Authors:  Sarah Adams Schoenrock; Daniel Oreper; Nancy Young; Robin Betsch Ervin; Molly A Bogue; William Valdar; Lisa M Tarantino
Journal:  Physiol Behav       Date:  2016-09-29

7.  Depression, quality of life, work productivity, resource use, and costs among women experiencing menopause and hot flashes: a cross-sectional study.

Authors:  Marco Dacosta Dibonaventura; Jan-Samuel Wagner; Jose Alvir; Jennifer Whiteley
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-01

8.  Employment status, depressive symptoms, and waist circumference change in midlife women: the Study of Women's Health Across the Nation (SWAN).

Authors:  Bradley M Appelhans; Eisuke Segawa; Imke Janssen; Rasa Kazlauskaite; Rebecca C Thurston; Tené T Lewis; Howard M Kravitz
Journal:  Ann Epidemiol       Date:  2013-12-28       Impact factor: 3.797

Review 9.  Polymorphisms of estrogen receptors and risk of depression: therapeutic implications.

Authors:  Joanne Ryan; Marie-Laure Ancelin
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

10.  Patterns of depressive disorders across 13 years and their determinants among midlife women: SWAN mental health study.

Authors:  Joyce T Bromberger; Howard M Kravitz; Ada Youk; Laura L Schott; Hadine Joffe
Journal:  J Affect Disord       Date:  2016-07-05       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.